Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Goodwill & Intangibles (2020 - 2025)

Universe Pharmaceuticals' Goodwill & Intangibles history spans 6 years, with the latest figure at $473.9 million for Q3 2025.

  • On a quarterly basis, Goodwill & Intangibles rose 80.29% to $473.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $473.9 million, a 80.29% increase, with the full-year FY2025 number at $473.9 million, up 80.29% from a year prior.
  • Goodwill & Intangibles hit $473.9 million in Q3 2025 for Universe Pharmaceuticals, up from $262.9 million in the prior quarter.
  • Over the last five years, Goodwill & Intangibles for UPC hit a ceiling of $473.9 million in Q3 2025 and a floor of $147652.0 in Q1 2024.
  • Historically, Goodwill & Intangibles has averaged $92.2 million across 5 years, with a median of $222942.5 in 2022.
  • Biggest five-year swings in Goodwill & Intangibles: tumbled 100.0% in 2021 and later surged 98311.58% in 2024.
  • Tracing UPC's Goodwill & Intangibles over 5 years: stood at $148584.0 in 2021, then surged by 84.39% to $273974.0 in 2022, then decreased by 2.5% to $267121.0 in 2023, then surged by 98311.58% to $262.9 million in 2024, then surged by 80.29% to $473.9 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for UPC at $473.9 million in Q3 2025, $262.9 million in Q3 2024, and $147652.0 in Q1 2024.